Cognitive Functioning Among De Novo Heart Transplant Recipients on Everolimus-Based Immunosuppression

被引：0
|
作者：
Buerker, B. S. [1 ]
Andersson, S. [1 ]
Gullestad, L. [2 ]
Gude, E. [2 ]
Relbo, A. [2 ]
Grov, I. [2 ]
Malt, U. F. [3 ]
Andreassen, A. K. [2 ]
Fiane, A. E. [4 ]
Haraldsen, I. H. [1 ]
机构：
[1] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Psychosomat Med, N-0027 Oslo, Norway
[2] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Cardiol, N-0027 Oslo, Norway
[3] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Res & Educ, N-0027 Oslo, Norway
[4] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Thorac Surg, N-0027 Oslo, Norway
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2015年 / 34卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
645
引用
收藏
页码：S239 / S239
页数：1
相关论文
共 50 条
  • [41] EARLY EVEROLIMUS-BASED TACROLIMUS REDUCTION IN DE NOVO LIVER TRANSPLANT RECIPIENTS: DESIGN AND BASELINE DATA FROM HEPHAISTOS STUDY
    Nashan, B.
    Schemmer, P.
    Braun, F.
    Dworak, M.
    Wimmer, P.
    Schlitt, H.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S850 - S850
  • [42] Ab initio Everolimus-based Versus Standard Calcineurin Inhibitor Immunosuppression Regimen in Liver Transplant Recipients
    Manzia, T. M.
    Angelico, R.
    Toti, L.
    Grimaldi, C.
    Sforza, D.
    Vella, I.
    Tariciotti, L.
    Lenci, I.
    Breshanaj, G.
    Baiocchi, L.
    Tisone, G.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (01) : 175 - 183
  • [43] Predicting Adverse Events in Liver Transplant Patients on Everolimus-Based Immunosuppression
    De Simone, Paolo
    Carrai, Paola
    Coletti, Laura
    Precisi, Arianna
    Ghinolfi, Davide
    Filipponi, Franco
    TRANSPLANTATION, 2016, 100 : S227 - S227
  • [44] Pregnancy under everolimus-based immunosuppression
    Veroux, Massimiliano
    Corona, Daniela
    Veroux, Pierfrancesco
    TRANSPLANT INTERNATIONAL, 2011, 24 (12) : E115 - E117
  • [45] HEPHAISTOS STUDY: DESIGN AND BASELINE DATA FROM EARLY INITIATION OF EVEROLIMUS-BASED TACROLIMUS REDUCTION IN DE NOVO LIVER TRANSPLANT RECIPIENTS
    Nashan, B.
    Schemmer, P.
    Braun, F.
    Dworak, M.
    Wimmer, P.
    Schlitt, H.
    TRANSPLANT INTERNATIONAL, 2015, 28 : 316 - 316
  • [46] A lower incidence of cytomegalovirus infection in de novo heart transplant recipients randomized to everolimus
    Hill, James A.
    Hummel, Manfred
    Starling, Randall C.
    Kobashigawa, Jon A.
    Perrone, Sergio V.
    Arizon, Jose M.
    Simonsen, Svein
    Abeywickrama, Kamal H.
    Bara, Christoph
    TRANSPLANTATION, 2007, 84 (11) : 1436 - 1442
  • [47] Ab initio Everolimus-Based vs. Standard CNI Immunosuppression-Regimen in Liver Transplant Recipients
    Manzia, Tommaso Maria
    Quaranta, Claudia
    Toti, Luca
    Sforza, Daniele
    Pellicciaro, Marco
    Vella, Ivan
    Tariciotti, Laura
    Tisone, Giuseppe
    TRANSPLANTATION, 2018, 102 : S384 - S384
  • [48] Effect of Everolimus Based Immunosuppression on De Novo Heart Transplant Recipients-24 Months Efficacy and Safety Results from A2310 Study
    Kobashigawa, J.
    Pauly, D.
    Kfoury, A.
    Ross, H.
    Wang, S. -S.
    Cantin, B.
    van Bakel, A.
    Starling, R.
    Hirt, S.
    Dong, G.
    Panis, C.
    Lopez, P.
    Eisen, H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 67 - 68
  • [49] Increased Risk of Venous Thromboembolism With Everolimus-Based Immunosuppression in Lung Transplant Recipients: A Case-Controlled Study
    Schoeppler, K.
    Lyu, D.
    Grazia, T.
    Crossno, J., Jr.
    Vandervest, K.
    Zamora, M.
    TRANSPLANTATION, 2014, 98 : 804 - 805
  • [50] Everolimus in de novo liver transplant recipients: a systematic review
    Cheng-Yong Tang
    Ai Shen
    Xu-Fu Wei
    Qing-Dong Li
    Rui Liu
    He-Jun Deng
    Yong-Zhong Wu
    Zhong-Jun Wu
    Hepatobiliary & Pancreatic Diseases International, 2015, 14 (05) : 461 - 469
12345